CCBR A/S
About CCBR A/S
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Nordic Bioscience A/S
5
Pfizer
5
Kowa Research Europe
2
Menarini Group
1
Statens Serum Institut
1
Unigene Laboratories Inc.
1
Clinical Trials at CCBR A/S
During the past decade, CCBR A/S conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 5 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study to Compare the Efficacy and Safety of Pitavastatin and Simvastatin
2005-09-01
2006-10-01
Completed
355
Study Comparing Pitavastatin and Atorvastatin in Patients With Type II Diabetes Mellitus and Combined Dyslipidemia
2005-12-01
2007-06-01
Completed
418
Pharmacokinetics/Pharmacodynamics of Oral Salmon Calcitonin in Patients With Osteoarthritis
2005-10-01
Completed
SMC021A - Absorption, Efficacy and Tolerance in Patients With Osteoarthritis. A Placebo-Controlled 14-Days Study
2007-01-01
Completed
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis
2007-05-01
2010-09-01
Completed
1,176
A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D
2007-03-01
2011-11-01
Completed
4,665
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis (OA 2 Study)
2008-06-01
2011-06-01
Terminated
1,030
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "CCBR A/S" #1 sponsor was "Nordic Bioscience A/S" with 5 trials, followed by "Pfizer" with 5 trials
sponsored, "Kowa Research Europe" with 2 trials sponsored, "Menarini Group" with 1 trials sponsored and "Statens Serum Institut"
with 1 trials sponsored. Other sponsors include -4 different institutions and
companies that sponsored additional 6 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "CCBR A/S"
#1 collaborator was "Novartis" with 5 trials as a collaborator, "GlaxoSmithKline" with 2 trials as a collaborator, "Bill and Melinda Gates Foundation" with 1 trials as a collaborator, "CCBR Clinical Research" with 1 trials as a collaborator and "Larix A/S" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at CCBR A/S
According to Clinical.Site data, the most researched conditions in "CCBR A/S" are
"Osteoarthritis" (5 trials), "Cardiovascular Disease" (2 trials), "Dyslipidemia" (2 trials), "Smoking Cessation" (2 trials) and "Hypercholesterolemia" (1 trials). Many other conditions were trialed in "CCBR A/S" in a lesser frequency.
Clinical Trials Intervention Types at CCBR A/S
Most popular intervention types in "CCBR A/S" are "Drug" (14 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Nicotine Replacement Therapy Patch" (2 trials), "SMC021 Placebo" (2 trials), "bococizumab (PF-04950615)" (2 trials) and "bupropion hydrochloride" (2 trials). Other intervention names were less common.
Clinical Trials Genders at CCBR A/S
The vast majority of trials in "CCBR A/S" are
13 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at CCBR A/S
Currently, there are NaN active trials in "CCBR A/S".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 11 completed trials in CCBR A/S,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in CCBR A/S, 3 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 8 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 0 trials that are defined as “Not Applicable".